Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Mar 15, 2025; 17(3): 102187
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.102187
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.102187
Table 1 Core targets and topological parameters
| Name | Betweenness | Closeness | Degree |
| TP53 | 537.5688911 | 0.011111111 | 58 |
| HSP90AA1 | 411.5735117 | 0.010416667 | 53 |
| STAT3 | 280.5350034 | 0.010309278 | 52 |
| AKT1 | 451.5531513 | 0.010204082 | 50 |
| SRC | 297.0466707 | 0.01 | 49 |
| EGFR | 222.7036191 | 0.00990099 | 48 |
| CASP3 | 233.6425731 | 0.009803922 | 47 |
| PIK3CA | 159.1340985 | 0.00952381 | 46 |
| MTOR | 126.8320074 | 0.009433962 | 43 |
| ESR1 | 202.0774342 | 0.009345794 | 43 |
| HIF1A | 109.3920337 | 0.009259259 | 41 |
| MDM2 | 66.2593338 | 0.008928571 | 37 |
| MMP9 | 230.2669059 | 0.00877193 | 34 |
| PPARG | 269.6527851 | 0.008695652 | 33 |
| KDR | 65.5729245 | 0.008130081 | 26 |
| AR | 63.40344608 | 0.008064516 | 26 |
Table 2 Docking scores of tetrahydrocurcumin with core target molecules
| Name | PDB ID | Target protein scoring, total score |
| PIK3CA | 5DXT | 9.2428 |
| KDR | 2XIR | 9.1786 |
| EGFR | 3POZ | 9.0041 |
| MMP9 | 6ESM | 8.7419 |
| HSP90AA1 | 1BYQ | 8.5337 |
| STAT3 | 5AX3 | 7.9753 |
| PPARG | 3B1M | 7.9106 |
| MTOR | 4DRI | 7.8581 |
| AR | 1T65 | 7.6085 |
| AKT1 | 4GV1 | 6.6415 |
| TP53 | 1XQH | 6.5781 |
| CASP3 | 1NMS | 6.2940 |
| MDM2 | 4HG7 | 6.1486 |
| ESR1 | 3CBP | 5.9387 |
| HIF1A | 6GMR | 5.6041 |
| SRC | 1O41 | 4.2536 |
- Citation: Bao ZC, Liu ZD, Zhang Y, Dai HJ, Jia H, Ren F, Li N, Zhao L, Wang YW, Lv SY, Zhang Y. To investigate the effect and mechanism of tetrahydrocurcumin on hepatocellular carcinoma based on phosphoinositide 3-kinases/AKT signaling pathway. World J Gastrointest Oncol 2025; 17(3): 102187
- URL: https://www.wjgnet.com/1948-5204/full/v17/i3/102187.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i3.102187
